$CERS
Cerus Corp Stock $cers

$cers Overview Financials Valuation SEC Filings Company Website

2016 Q1 Form 10-Q Financial Statement

#000119312516582028 Filed on May 06, 2016

Income Statement

Concept	2016 Q1	2015 Q1
Revenue	$7.632M	$7.692M
YoY Change	-0.78%	-2.21%
Cost Of Revenue	$4.263M	$4.714M
YoY Change	-9.57%	13.4%
Gross Profit	$3.369M	$2.978M
YoY Change	13.13%	-19.71%
Gross Profit Margin	44.14%	38.72%
Selling, General & Admin	$11.75M	$11.72M
YoY Change	0.25%	42.28%
% of Gross Profit	348.68%	393.49%
Research & Development	$6.917M	$5.581M
YoY Change	23.94%	20.23%
% of Gross Profit	205.31%	187.41%
Depreciation & Amortization	$476.0K	$443.0K
YoY Change	7.45%	36.31%
% of Gross Profit	14.13%	14.88%
Operating Expenses	$18.71M	$17.35M
YoY Change	7.87%	34.2%
Operating Profit	-$15.35M	-$14.37M
YoY Change	6.78%	55.88%
Interest Expense	$655.0K	$255.0K
YoY Change	156.86%	410.0%
% of Operating Profit
Other Income/Expense, Net	-$706.0K	$4.930M
YoY Change	-114.32%	-45.42%
Pretax Income	-$16.05M	-$9.441M
YoY Change	70.01%	4948.66%
Income Tax	$812.0K	$19.00K
% Of Pretax Income
Net Earnings	-$16.86M	-$9.460M
YoY Change	78.26%	4104.44%
Net Earnings / Revenue	-220.95%	-122.98%
Basic Earnings Per Share	-$0.17	-$0.10
Diluted Earnings Per Share	-$0.17	-$0.17
COMMON SHARES
Basic Shares Outstanding	99.47M	93.41M shares
Diluted Shares Outstanding	99.47M	94.66M shares

Balance Sheet

Concept	2016 Q1	2015 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$91.30M	$111.9M
YoY Change	-18.41%	131.68%
Cash & Equivalents	$20.79M	$17.93M
Short-Term Investments	$70.51M	$94.00M
Other Short-Term Assets	$6.333M	$1.933M
YoY Change	227.63%	111.72%
Inventory	$11.26M	$16.11M
Prepaid Expenses	$1.377M	$1.331M
Receivables	$4.086M	$5.153M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$119.4M	$136.4M
YoY Change	-12.45%	103.37%
LONG-TERM ASSETS
Property, Plant & Equipment	$3.380M	$3.797M
YoY Change	-10.98%	19.93%
Goodwill	$1.316M	$1.316M
YoY Change	0.0%	0.0%
Intangibles		$1.092M
YoY Change		-15.61%
Long-Term Investments
YoY Change
Other Assets	$2.341M	$140.0K
YoY Change	1572.14%	118.75%
Total Long-Term Assets	$8.501M	$6.806M
YoY Change	24.9%	10.7%
TOTAL ASSETS
Total Short-Term Assets	$119.4M	$136.4M
Total Long-Term Assets	$8.501M	$6.806M
Total Assets	$127.9M	$143.2M
YoY Change	-10.67%	95.59%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$6.238M	$10.51M
YoY Change	-40.65%	200.89%
Accrued Expenses	$9.221M	$7.104M
YoY Change	29.8%	-19.62%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due	$4.500M	$600.0K
YoY Change	650.0%	-81.82%
Total Short-Term Liabilities	$22.82M	$22.76M
YoY Change	0.24%	-16.41%
LONG-TERM LIABILITIES
Long-Term Debt	$15.30M	$9.300M
YoY Change	64.52%
Other Long-Term Liabilities	$1.314M	$1.116M
YoY Change	17.74%	8.24%
Total Long-Term Liabilities	$1.314M	$1.116M
YoY Change	17.74%	8.24%
TOTAL LIABILITIES
Total Short-Term Liabilities	$22.82M	$22.76M
Total Long-Term Liabilities	$1.314M	$1.116M
Total Liabilities	$44.40M	$33.29M
YoY Change	33.39%	17.38%
SHAREHOLDERS EQUITY
Retained Earnings	-$614.7M	-$551.4M
YoY Change	11.47%	9.53%
Common Stock	$694.8M	$661.4M
YoY Change	5.06%	918445.83%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$83.53M	$109.9M
YoY Change
Total Liabilities & Shareholders Equity	$127.9M	$143.2M
YoY Change	-10.67%	95.59%

Cashflow Statement

Concept	2016 Q1	2015 Q1
OPERATING ACTIVITIES
Net Income	-$16.86M	-$9.460M
YoY Change	78.26%	4104.44%
Depreciation, Depletion And Amortization	$476.0K	$443.0K
YoY Change	7.45%	36.31%
Cash From Operating Activities	-$13.04M	-$15.75M
YoY Change	-17.21%	60.22%
INVESTING ACTIVITIES
Capital Expenditures	$43.00K	$59.00K
YoY Change	-27.12%	-92.97%
Acquisitions
YoY Change
Other Investing Activities	-$45.04M	-$65.54M
YoY Change	-31.28%	-14347.83%
Cash From Investing Activities	-$45.09M	-$65.59M
YoY Change	-31.25%	-2286.33%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net	$7.199M	$75.53M
YoY Change	-90.47%	243535.48%
Debt Paid & Issued, Net	$32.00K	$28.00K
YoY Change	14.29%	-77.6%
Cash From Financing Activities	7.870M	76.50M
YoY Change	-89.71%	5651.88%
NET CHANGE
Cash From Operating Activities	-13.04M	-15.75M
Cash From Investing Activities	-45.09M	-65.59M
Cash From Financing Activities	7.870M	76.50M
Net Change In Cash	-50.26M	-4.840M
YoY Change	938.43%	-12.0%
FREE CASH FLOW
Cash From Operating Activities	-$13.04M	-$15.75M
Capital Expenditures	$43.00K	$59.00K
Free Cash Flow	-$13.08M	-$15.81M
YoY Change	-17.24%	48.18%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2016Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	101710815	shares
CY2015Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	17934000
CY2016Q1	us-gaap	Liabilities Current LiabilitiesCurrent	22818000
CY2016Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	4664000
CY2016Q1	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	131000
CY2016Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	9221000
CY2016Q1	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	1600000
CY2016Q1	us-gaap	Liabilities Liabilities	44404000
CY2016Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	6428000
CY2016Q1	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	0
CY2016Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	1127000
CY2016Q1	us-gaap	Common Stock Value CommonStockValue	101000
CY2016Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	694741000
CY2016Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	3050000
CY2016Q1	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	5155000
CY2016Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	1314000
CY2016Q1	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	613000
CY2016Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	3367000
CY2016Q1	us-gaap	Secured Debt Current SecuredDebtCurrent	4527000
CY2016Q1	us-gaap	Long Term Debt LongTermDebt	20000000
CY2016Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2016Q1	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	2808000
CY2016Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	606000
CY2016Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-614675000
CY2016Q1	us-gaap	Accrued Insurance Current AccruedInsuranceCurrent	220000
CY2016Q1	us-gaap	Stockholders Equity StockholdersEquity	83534000
CY2016Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	127938000
CY2016Q1	us-gaap	Secured Long Term Debt SecuredLongTermDebt	15301000
CY2016Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	3630000
CY2016Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	6892000
CY2016Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	6238000
CY2016Q1	us-gaap	Available For Sale Securities AvailableForSaleSecurities	82243000
CY2016Q1	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	574000
CY2016Q1	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	8289000
CY2016Q1	us-gaap	Accounts And Notes Receivable Net AccountsAndNotesReceivableNet	900000
CY2016Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3380000
CY2016Q1	us-gaap	Assets Current AssetsCurrent	119437000
CY2016Q1	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost	20175000
CY2016Q1	us-gaap	Other Assets Current OtherAssetsCurrent	6333000
CY2016Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	200000
CY2016Q1	us-gaap	Goodwill Goodwill	1316000
CY2016Q1	us-gaap	Available For Sale Securities Debt Maturities Within One Year Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost	56934000
CY2016Q1	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValue	18137000
CY2016Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	100000
CY2016Q1	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	56934000
CY2016Q1	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	2017000
CY2016Q1	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	1377000
CY2016Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	890000
CY2016Q1	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss	21000
CY2016Q1	us-gaap	Available For Sale Securities Equity Securities Current AvailableForSaleSecuritiesEquitySecuritiesCurrent	5082000
CY2016Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	20791000
CY2016Q1	us-gaap	Available For Sale Equity Securities Amortized Cost Basis AvailableForSaleEquitySecuritiesAmortizedCostBasis	0
CY2016Q1	us-gaap	Cost Method Investments CostMethodInvestments	0
CY2016Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	200000
CY2016Q1	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	2966000
CY2016Q1	us-gaap	Assets Assets	127938000
CY2016Q1	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	21000
CY2016Q1	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue	20227000
CY2016Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	150000
CY2016Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	4086000
CY2016Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	2341000
CY2016Q1	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Accumulated Loss AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLoss	21000
CY2016Q1	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	77109000
CY2016Q1	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue	18137000
CY2016Q1	us-gaap	Inventory Net InventoryNet	11255000
CY2016Q1	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	70513000
CY2016Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	200000
CY2016Q1	cers	Long Term Debt Maturities Repayments Of Interest In Year Four LongTermDebtMaturitiesRepaymentsOfInterestInYearFour	1474000
CY2016Q1	cers	Long Term Debt Maturities Repayments Of Principal And Interest LongTermDebtMaturitiesRepaymentsOfPrincipalAndInterest	23974000
CY2016Q1	cers	Long Term Debt Maturities Repayments Of Interest LongTermDebtMaturitiesRepaymentsOfInterest	3974000
CY2016Q1	cers	Long Term Debt Maturities Repayments Of Principal And Interest In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalAndInterestInNextTwelveMonths	4053000
CY2016Q1	cers	Debt Instrument Unamortized Current DebtInstrumentUnamortizedCurrent	88000
CY2016Q1	cers	Long Term Debt Maturities Repayments Of Principal And Interest In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalAndInterestInYearTwo	7408000
CY2016Q1	cers	Longterm Debt Maturities Repaymentsof Interestin Next Twelve Months LongtermDebtMaturitiesRepaymentsofInterestinNextTwelveMonths	1003000
CY2016Q1	cers	Long Term Debt Maturities Repayments Of Interest In Year Three LongTermDebtMaturitiesRepaymentsOfInterestInYearThree	517000
CY2016Q1	cers	Debt Instrument Unamortized Noncurrent DebtInstrumentUnamortizedNoncurrent	84000
CY2016Q1	cers	Long Term Debt Maturities Repayments Of Principal And Interest In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalAndInterestInYearThree	7409000
CY2016Q1	cers	Debt Instrument Carrying Non Current DebtInstrumentCarryingNonCurrent	15385000
CY2016Q1	cers	Accrued Customer Costs Current AccruedCustomerCostsCurrent	923000
CY2016Q1	cers	Cumulative Outstanding Trade Receivables Number Of Major Customers CumulativeOutstandingTradeReceivablesNumberOfMajorCustomers	2	Customer
CY2016Q1	cers	Long Term Debt Maturities Repayments Of Principal And Interest In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalAndInterestInYearFour	5104000
CY2016Q1	cers	Long Term Debt Maturities Repayments Of Interest In Year Two LongTermDebtMaturitiesRepaymentsOfInterestInYearTwo	980000
CY2016Q1	cers	Debt Instrument Carrying Current DebtInstrumentCarryingCurrent	4615000
CY2016Q1	cers	Accrued Leasehold Improvements Current And Accrued Leasehold Improvements Noncurrent AccruedLeaseholdImprovementsCurrentAndAccruedLeaseholdImprovementsNoncurrent	500000
CY2016Q1	cers	Accrual For Manufacturing And Development Payment Liability Current AccrualForManufacturingAndDevelopmentPaymentLiabilityCurrent	2219000
CY2016Q1	cers	Accrual For Manufacturing And Development Payment Liability Noncurrent AccrualForManufacturingAndDevelopmentPaymentLiabilityNoncurrent	4840000
CY2014Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	22781000
CY2015Q4	us-gaap	Liabilities Current LiabilitiesCurrent	21862000
CY2015Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	5198000
CY2015Q4	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	122000
CY2015Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	9853000
CY2015Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3549000
CY2015Q4	us-gaap	Assets Current AssetsCurrent	130406000
CY2015Q4	us-gaap	Other Assets Current OtherAssetsCurrent	4755000
CY2015Q4	us-gaap	Goodwill Goodwill	1316000
CY2015Q4	us-gaap	Available For Sale Securities Debt Maturities Within One Year Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost	85049000
CY2015Q4	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValue	25698000
CY2015Q4	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	85000000
CY2015Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	1800000
CY2015Q4	us-gaap	Liabilities Liabilities	44637000
CY2015Q4	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	0
CY2015Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	1077000
CY2015Q4	us-gaap	Common Stock Value CommonStockValue	99000
CY2015Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	685189000
CY2015Q4	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	11163000
CY2015Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	1263000
CY2015Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	554000
CY2015Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	7289000
CY2015Q4	us-gaap	Secured Debt Current SecuredDebtCurrent	2956000
CY2015Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2015Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	2337000
CY2015Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	893000
CY2015Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-597812000
CY2015Q4	us-gaap	Accrued Insurance Current AccruedInsuranceCurrent	438000
CY2015Q4	us-gaap	Stockholders Equity StockholdersEquity	94765000
CY2015Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	139402000
CY2015Q4	us-gaap	Secured Long Term Debt SecuredLongTermDebt	16848000
CY2015Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	5217000
CY2015Q4	us-gaap	Available For Sale Securities AvailableForSaleSecurities	96163000
CY2015Q4	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	612000
CY2015Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	7625000
CY2015Q4	us-gaap	Accounts And Notes Receivable Net AccountsAndNotesReceivableNet	200000
CY2015Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	2017000
CY2015Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	1166000
CY2015Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	940000
CY2015Q4	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss	46000
CY2015Q4	us-gaap	Available For Sale Securities Equity Securities Current AvailableForSaleSecuritiesEquitySecuritiesCurrent	11163000
CY2015Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	71018000
CY2015Q4	us-gaap	Available For Sale Equity Securities Amortized Cost Basis AvailableForSaleEquitySecuritiesAmortizedCostBasis	0
CY2015Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	3187000
CY2015Q4	us-gaap	Assets Assets	139402000
CY2015Q4	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	49000
CY2015Q4	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss	3000
CY2015Q4	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Twelve Months Or Longer Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue	5528000
CY2015Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	5794000
CY2015Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	2579000
CY2015Q4	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Accumulated Loss AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLoss	49000
CY2015Q4	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	85049000
CY2015Q4	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue	20170000
CY2015Q4	us-gaap	Inventory Net InventoryNet	10812000
CY2015Q4	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	25698000
CY2015Q4	cers	Debt Instrument Unamortized Current DebtInstrumentUnamortizedCurrent	94000
CY2015Q4	cers	Debt Instrument Unamortized Noncurrent DebtInstrumentUnamortizedNoncurrent	102000
CY2015Q4	cers	Debt Instrument Carrying Non Current DebtInstrumentCarryingNonCurrent	16950000
CY2015Q4	cers	Accrued Customer Costs Current AccruedCustomerCostsCurrent	987000
CY2015Q4	cers	Cumulative Outstanding Trade Receivables Number Of Major Customers CumulativeOutstandingTradeReceivablesNumberOfMajorCustomers	3	Customer
CY2015Q4	cers	Debt Instrument Carrying Current DebtInstrumentCarryingCurrent	3050000
CY2015Q4	cers	Accrual For Manufacturing And Development Payment Liability Current AccrualForManufacturingAndDevelopmentPaymentLiabilityCurrent	3282000
CY2015Q4	cers	Accrual For Manufacturing And Development Payment Liability Noncurrent AccrualForManufacturingAndDevelopmentPaymentLiabilityNoncurrent	4542000
CY2010	cers	Proceeds From Landlord Financing Leasehold Improvement ProceedsFromLandlordFinancingLeaseholdImprovement	1100000
CY2015Q1	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	1251000	shares
CY2015Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	93411000	shares
CY2015Q1	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-15751000
CY2015Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.10
CY2015Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	94662000	shares
CY2015Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.17
CY2015Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	116000
CY2015Q1	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-1113000
CY2015Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-9441000
CY2015Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	59000
CY2015Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	2000
CY2015Q1	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	69982000
CY2015Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-14371000
CY2015Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	1220000
CY2015Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-9441000
CY2015Q1	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-15756000
CY2015Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-340000
CY2015Q1	us-gaap	Increase Decrease In Restricted Cash IncreaseDecreaseInRestrictedCash	-47000
CY2015Q1	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	28000
CY2015Q1	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	7692000
CY2015Q1	us-gaap	Dilutive Securities DilutiveSecurities	-6296000
CY2015Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	4930000
CY2015Q1	us-gaap	Net Income Loss NetIncomeLoss	-9460000
CY2015Q1	us-gaap	Gross Profit GrossProfit	2978000
CY2015Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	19000
CY2015Q1	us-gaap	Interest Expense InterestExpense	255000
CY2015Q1	us-gaap	Available For Sale Securities Gross Realized Gains AvailableForSaleSecuritiesGrossRealizedGains	0
CY2015Q1	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-65594000
CY2015Q1	us-gaap	Cost Of Goods Sold CostOfGoodsSold	4714000
CY2015Q1	us-gaap	Available For Sale Securities Gross Realized Losses AvailableForSaleSecuritiesGrossRealizedLosses	0
CY2015Q1	cers	Payment For Manufacturing Of Entity Products PaymentForManufacturingOfEntityProducts	4700000
CY2015Q1	cers	Non Cash Interest Expense NonCashInterestExpense	64000
CY2015Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	75527000
CY2015Q1	us-gaap	Operating Expenses OperatingExpenses	17349000
CY2015Q1	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	76498000
CY2015Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	50000
CY2015Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax	0
CY2015Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	443000
CY2015Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	19000
CY2015Q1	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	4400000
CY2015Q1	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	5581000
CY2015Q1	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	999000
CY2015Q1	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	23000
CY2015Q1	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-6296000
CY2015Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	1000
CY2015Q1	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-4847000
CY2015Q1	us-gaap	Impairment Of Investments ImpairmentOfInvestments	0
CY2015Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	484000
CY2015Q1	us-gaap	Share Based Compensation ShareBasedCompensation	1474000
CY2015Q1	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0
CY2015Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	11718000
CY2015Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-1488000
CY2015Q1	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	0
CY2016Q1	dei	Document Type DocumentType	10-Q
CY2016Q1	dei	Trading Symbol TradingSymbol	CERS
CY2016Q1	us-gaap	Acquired Finite Lived Intangible Assets Weighted Average Useful Life AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife	P10Y
CY2016Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001020214
CY2016Q1	dei	Document Period End Date DocumentPeriodEndDate	2016-03-31
CY2016Q1	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
CY2016Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2016Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2016Q1	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"> <b>Concentration of Credit Risk</b></p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt"> Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash equivalents, available-for-sale securities and accounts receivable.</p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt"> Pursuant to the Company’s investment policy, substantially all of the Company’s cash, cash equivalents and available-for-sale securities are maintained at major financial institutions of high credit standing. The Company monitors the financial credit worthiness of the issuers of its investments and limits the concentration in individual securities and types of investments that exist within its investment portfolio. Generally, all of the Company’s investments carry high credit quality ratings, which is in accordance with its investment policy. At March 31, 2016, the fair value of the Company’s marketable equity securities of Aduro is subject to the underlying volatility of Aduro’s stock price. At March 31, 2016, the Company does not believe there is significant financial risk from non-performance by the issuers of the Company’s cash equivalents and short-term investments.</p> <p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 1px; MARGIN-TOP: 12px">  </p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 0pt"> Concentrations of credit risk with respect to trade receivables exist. On a regular basis, including at the time of sale, the Company performs credit evaluations of its significant customers that it expects to sell to on credit terms. Generally, the Company does not require collateral from its customers to secure accounts receivable. To the extent that the Company determines specific invoices or customer accounts may be uncollectible, the Company establishes an allowance for doubtful accounts against the accounts receivable on its unaudited condensed consolidated balance sheets and records a charge on its unaudited condensed consolidated statements of operations as a component of selling, general and administrative expenses.</p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt"> The Company had two customers and three customers that accounted for more than 10% of the Company’s outstanding trade receivables at March 31, 2016 and December 31, 2015, respectively. These customers cumulatively represented approximately 48% and 49% of the Company’s outstanding trade receivables at March 31, 2016 and December 31, 2015, respectively. To date, the Company has not experienced collection difficulties from these customers.</p> </div>
CY2016Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	99471000	shares
CY2016Q1	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-13043000
CY2016Q1	dei	Amendment Flag AmendmentFlag	false
CY2016Q1	us-gaap	Guarantees Indemnifications And Warranties Policies GuaranteesIndemnificationsAndWarrantiesPolicies	<div> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"> <b>Guarantee and Indemnification Arrangements</b></p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt"> The Company recognizes the fair value for guarantee and indemnification arrangements issued or modified by the Company. In addition, the Company monitors the conditions that are subject to the guarantees and indemnifications in order to identify if a loss has occurred. If the Company determines it is probable that a loss has occurred, then any such estimable loss would be recognized under those guarantees and indemnifications. Some of the agreements that the Company is a party to contain provisions that indemnify the counter party from damages and costs resulting from claims that the Company’s technology infringes the intellectual property rights of a third party or claims that the sale or use of the Company’s products have caused personal injury or other damage or loss. The Company has not received any such requests for indemnification under these provisions and has not been required to make material payments pursuant to these provisions.</p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt"> The Company generally provides for a one-year warranty on certain of its INTERCEPT blood-safety products covering defects in materials and workmanship. The Company accrues costs associated with warranty obligations when claims become known and are estimable. The Company has not experienced significant or systemic warranty claims nor is it aware of any existing current warranty claims. Accordingly, the Company had not accrued for any future warranty costs for its products at March 31, 2016 and December 31, 2015.</p> </div>
CY2016Q1	dei	Entity Registrant Name EntityRegistrantName	CERUS CORP
CY2016Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-706000
CY2016Q1	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	1	Segment
CY2016Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.17
CY2016Q1	us-gaap	Use Of Estimates UseOfEstimates	<div> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"> <b>Use of Estimates</b></p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt"> The preparation of financial statements requires management to make estimates, assumptions and judgments that affect the reported amounts of assets, liabilities, revenue and expenses, and related disclosures of contingent assets and liabilities. On an ongoing basis, management evaluates its estimates, which are based on historical experience and on various other assumptions that are believed to be reasonable under the circumstances. Actual results may differ from those estimates under different assumptions or conditions.</p> </div>
CY2016Q1	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	Segment
CY2016Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2016
CY2016Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	99471000	shares
CY2016Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.17
CY2016Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	213000
CY2016Q1	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-117000
CY2016Q1	us-gaap	Goodwill Other Changes GoodwillOtherChanges	0
CY2016Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-20785000
CY2016Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	43000
CY2016Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	66000
CY2016Q1	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	50544000
CY2016Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-15345000
CY2016Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	488000
CY2016Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-16051000
CY2016Q1	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-16863000
CY2016Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-1708000
CY2016Q1	us-gaap	Increase Decrease In Restricted Cash IncreaseDecreaseInRestrictedCash	-38000
CY2016Q1	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	32000
CY2016Q1	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	7632000
CY2016Q1	us-gaap	Net Income Loss NetIncomeLoss	-16863000
CY2016Q1	us-gaap	Gross Profit GrossProfit	3369000
CY2016Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-3922000
CY2016Q1	us-gaap	Available For Sale Securities Gross Realized Gains AvailableForSaleSecuritiesGrossRealizedGains	0
CY2016Q1	us-gaap	Interest Expense InterestExpense	655000
CY2016Q1	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0
CY2016Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	7199000
CY2016Q1	us-gaap	Operating Expenses OperatingExpenses	18714000
CY2016Q1	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	7865000
CY2016Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	50000
CY2016Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax	-2058000
CY2016Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	476000
CY2016Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	812000
CY2016Q1	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	5500000
CY2016Q1	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	6917000
CY2016Q1	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	698000
CY2016Q1	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	52000
CY2016Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	9000
CY2016Q1	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-50227000
CY2016Q1	us-gaap	Impairment Of Investments ImpairmentOfInvestments	0
CY2016Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	995000
CY2016Q1	us-gaap	Share Based Compensation ShareBasedCompensation	1776000
CY2016Q1	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0
CY2016Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	11747000
CY2016Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-639000
CY2016Q1	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	0
CY2016Q1	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-45049000
CY2016Q1	us-gaap	Cost Of Goods Sold CostOfGoodsSold	4263000
CY2016Q1	us-gaap	Available For Sale Securities Gross Realized Losses AvailableForSaleSecuritiesGrossRealizedLosses	0
CY2016Q1	cers	Work In Process Inventory Life Period WorkInProcessInventoryLifePeriod	P1Y
CY2016Q1	cers	Product Warranty Term ProductWarrantyTerm	P1Y
CY2016Q1	cers	Minimum Term Of Non Cancelable Operating Leases MinimumTermOfNonCancelableOperatingLeases	P1Y
CY2016Q1	cers	Payment For Manufacturing Of Entity Products PaymentForManufacturingOfEntityProducts	3600000
CY2016Q1	cers	Expiration Of Non Cancelable Operating Leases Maximum Year ExpirationOfNonCancelableOperatingLeasesMaximumYear	2020
CY2016Q1	cers	Inventory Life Finished Goods Period InventoryLifeFinishedGoodsPeriod	P2Y
CY2016Q1	cers	Non Cash Interest Expense NonCashInterestExpense	300000
CY2016Q1	cers	Non Cash Tax Expense From Other Unrealized Gain Loss On Available For Sale Securities NonCashTaxExpenseFromOtherUnrealizedGainLossOnAvailableForSaleSecurities	768000
CY2016Q1	cers	Increase Decrease In Manufacturing And Development Payment Liability IncreaseDecreaseInManufacturingAndDevelopmentPaymentLiability	-924000

Files In Submission

Name	View Source	Status
0001193125-16-582028-index-headers.html	Edgar Link	pending
0001193125-16-582028-index.html	Edgar Link	pending
0001193125-16-582028.txt	Edgar Link	pending
0001193125-16-582028-xbrl.zip	Edgar Link	pending
cers-20160331.xml	Edgar Link	completed
cers-20160331.xsd	Edgar Link	pending
cers-20160331_cal.xml	Edgar Link	unprocessable
cers-20160331_def.xml	Edgar Link	unprocessable
cers-20160331_lab.xml	Edgar Link	unprocessable
cers-20160331_pre.xml	Edgar Link	unprocessable
d168140d10q.htm	Edgar Link	pending
d168140dex101.htm	Edgar Link	pending
d168140dex102.htm	Edgar Link	pending
d168140dex103.htm	Edgar Link	pending
d168140dex311.htm	Edgar Link	pending
d168140dex312.htm	Edgar Link	pending
d168140dex321.htm	Edgar Link	pending
d168140dex51.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
g168140ex10_3pg007.jpg	Edgar Link	pending
g168140ex51pg001.jpg	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CERS
Cerus Corp Stock $cers

2016 Q1 Form 10-Q Financial Statement

#000119312516582028 Filed on May 06, 2016

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CERS Cerus Corp Stock $cers

2016 Q1 Form 10-Q Financial Statement

#000119312516582028 Filed on May 06, 2016

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CERS
Cerus Corp Stock $cers